05/11/2026
Low-dose daily PDE5 inhibitors aren’t about walking around “aroused” all day. They work by improving nitric oxide signaling and blood flow throughout the body including the brain and vascular system, which is why they’re being studied for cardiovascular and cognitive health benefits.
PT-141 is different. It works centrally through melanocortin receptors in the brain and is designed to influence arousal pathways directly rather than simply improving circulation. Different mechanisms. Different goals. Modern medicine is finally starting to separate blood flow from desire.